Safety and Efficacy of Short-Term Oral Immunotherapy With Cry J 1-Galactomannan Conjugate for Japanese Cedar Pollinosis: A Randomized Controlled Trial

Scientific Reports - United Kingdom
doi 10.1038/srep46142
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Efficacy of the Cedar Antigen-Specific Subcutaneous Immunotherapy for Japanese Cedar/Cypress Pollinosis

Nihon Bika Gakkai Kaishi (Japanese Journal of Rhinology)
2016English

Transcutaneous Delivery of Immunomodulating Pollen Extract-Galactomannan Conjugate by Solid-In-Oil Nanodispersions for Pollinosis Immunotherapy

Pharmaceutics
Pharmaceutical Science
2019English

Seroprevalence of Immunoglobulin E Antibodies Against Japanese Cedar Pollen Allergens Cry J 1 and Cry J 2 in Dogs Bred in Japan

Veterinary Sciences
Veterinary
2018English

Efficacy and Safety of AR101 in Oral Immunotherapy for Peanut Allergy: Results of ARC001, a Randomized, Double-Blind, Placebo-Controlled Phase 2 Clinical Trial

Pediatrics
Child HealthPediatricsPerinatology
2018English

Safety of Sequential Sublingual Immunotherapy With Japanese Cedar Pollen and Mite Allergens

Journal of Otolaryngology of Japan
Otorhinolaryngology
2019English

Long-Lasting Effect of Allergen-Specific Sublingual Immunotherapy in a Murine Model of Japanese Cedar Pollinosis

Journal of Allergy and Clinical Immunology
AllergyImmunology
2017English

Treatment With Aqueous Beclomethasone Dipropionate Nasal Spray for Japanese Cedar Pollinosis.

Practica Otologica
Otorhinolaryngology
1997English

Three-Year Statistical Study of Japanese Cedar Pollinosis.

Practica Otologica
Otorhinolaryngology
1992English

Short-Term Subcutaneous Grass Pollen Immunotherapy Under the Umbrella of Anti–IL-4: A Randomized Controlled Trial

Journal of Allergy and Clinical Immunology
AllergyImmunology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy